Amanda Feilding Microdosing Big Steps in Small Doses

Microdosing offers a promising window into mental health by engaging neuroplasticity without inducing the intense mystical states associated with full psychedelic doses. These smaller, more manageable doses appear to facilitate functional changes in brain activity, mood, and cognitive performance through the modulation of neuroplastic signaling. Neuroimaging research indicates that psychedelics, including LSD and psilocybin, can reduce blood flow to the Default Mode Network and boost connectivity across disparate brain regions. This promotes a more fluid and less constrained state of consciousness, providing a biological basis for the profound psychological shifts often observed in clinical settings.